Cramer's lightning round: Enbridge is a buy

Blackline Inc: “They’re losing money. … We can just not go with it.”

Enbridge Inc: “That is exactly what you should be buying.”

AxoGen Inc: “It’s a medical device, and I think you have to stick with tried and true. .. Johnson & Johnson.”

MetLife Inc: “I’m going to have to say yes to that, even as I’m not a great fan of the insurers. … That is too cheap a stock.”

Bridge Investment Group Holdings: “We don’t really know what they do. … Pass, because there’s too much room for error.”

Farfetch Ltd: “I say, buy Target down here.”

Disclosure: Cramer’s Charitable Trust owns shares of Johnson & Johnson.

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money Twitter – Jim Cramer Twitter – Facebook – Instagram

Questions, comments, suggestions for the “Mad Money” website? [email protected]

This article was originally published by Cnbc.com. Read the original article here.

Cramer’s lightning round: Enbridge is a buy